by | Sep 18, 2024 | Publications
Clin Hematol Int. 2024 Jul 29;6(3):38-53. doi: 10.46989/001c.121406. eCollection 2024. ABSTRACT INTRODUCTION: Multiple myeloma (MM) is diagnosed in 6,000 people in the UK yearly. A performance status measure, based on the patients’ reported level of physical...
by | Sep 18, 2024 | Publications
Acta Haematol. 2024 Sep 16:1-17. doi: 10.1159/000540232. Online ahead of print. ABSTRACT INTRODUCTION: High-dose therapy with melphalan followed by autologous stem cell transplant at the upfront setting (upfront ASCT) has significantly improved clinical outcomes of...
by | Sep 9, 2024 | Publications
Oncologist. 2024 Sep 5:oyae219. doi: 10.1093/oncolo/oyae219. Online ahead of print. ABSTRACT BACKGROUND: Smoldering multiple myeloma (SMM), an asymptomatic precursor of multiple myeloma (MM), carries a variable risk of progression to MM. There is little consensus on...
by | Aug 24, 2024 | Publications
Clin Lymphoma Myeloma Leuk. 2024 Jul 19:S2152-2650(24)00264-7. doi: 10.1016/j.clml.2024.07.008. Online ahead of print. ABSTRACT BACKGROUND: Immunoparesis, defined as suppression of uninvolved polyclonal immunoglobulins, occurs in up to 80% of patients with newly...
by | Aug 19, 2024 | Publications
EJHaem. 2024 Jun 10;5(4):867-878. doi: 10.1002/jha2.905. eCollection 2024 Aug. ABSTRACT The incidence of multiple myeloma (MM) has surged globally, particularly in Latin American countries, and is attributable to an aging population and increased life expectancy. This...
by | Aug 15, 2024 | Publications
Front Oncol. 2024 Jul 31;14:1341631. doi: 10.3389/fonc.2024.1341631. eCollection 2024. ABSTRACT INTRODUCTION: Allogeneic hematopoietic cell transplantation (alloHCT) possessed direct cytotoxicity and graft-versus-multiple myeloma effect (GvMM). Growing trials have...
